| Ident. | Authors (with country if any) | Title |
|---|
| 000536 |
| Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials |
| 001482 |
| Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment- Experienced Patients with Drug- Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials |
| 001E52 |
| Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection |
| 001E96 |
| Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection |
